Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3806)
All Articles published online
|
Apr 21, 2012 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takino J, Yamagishi S, Takeuchi M. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression. World J Gastroenterol 2012; 18(15): 1781-1788 [PMID: 22553402 DOI: 10.3748/wjg.v18.i15.1781] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v18/i15/1781.htm |
| Number | Citing Articles |
| 1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_185-1
|
| 2 |
Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Masayoshi Takeuchi. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review. Nutrients 2019; 11(2): 462 doi: 10.3390/nu11020462
|
| 3 |
Gulcin Sahingoz Erdal, Mustafa Yaman, Esra Yıldırım Servi, Halime Ugur, Pinar Kasapoglu, Murat Cikot, Nilgun Isiksacan. Measurement of Advanced Glycation End Products Could Be Used as an Indicator of Unhealthy Nutrition for Colorectal Cancer Risk. Nutrition and Cancer 2022; 74(3): 896 doi: 10.1080/01635581.2021.1938148
|
| 4 |
Evelyn Nunes Goulart da Silva Pereira, Daniela Polessa Paula, Beatriz Peres de Araujo, Maria de Jesus Mendes da Fonseca, Maria de Fátima Haueisen Sander Diniz, Anissa Daliry, Rosane Harter Griep. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study. World Journal of Gastroenterology 2021; 27(29): 4913-4928 doi: 10.3748/wjg.v27.i29.4913
|
| 5 |
Marcus Hollenbach. The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC). International Journal of Molecular Sciences 2017; 18(11): 2466 doi: 10.3390/ijms18112466
|
| 6 |
Akiko Sakasai-Sakai, Takanobu Takata, Masayoshi Takeuchi. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells. International Journal of Molecular Sciences 2020; 21(14): 4861 doi: 10.3390/ijms21144861
|
| 7 |
Sho-ichi Yamagishi, Takanori Matsui. Role of receptor for advanced glycation end products (RAGE) in liver disease. European Journal of Medical Research 2015; 20(1) doi: 10.1186/s40001-015-0090-z
|
| 8 |
Ruyuan Deng, Huo Wu, Hui Ran, Xiang Kong, Lei Hu, Xiao Wang, Qing Su. Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(5): 1065 doi: 10.1016/j.bbagen.2017.02.024
|
| 9 |
Takanobu Takata, Tadashi Ueda, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotion. World Journal of Gastroenterology 2017; 23(27): 4910-4919 doi: 10.3748/wjg.v23.i27.4910
|
| 10 |
Ayako Ojima, Takanori Matsui, Sayaka Maeda, Masayoshi Takeuchi, Hiroyoshi Inoue, Yuichiro Higashimoto, Sho-ichi Yamagishi. DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice. Laboratory Investigation 2014; 94(4): 422 doi: 10.1038/labinvest.2014.5
|
| 11 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama. Effects of Toxic AGEs (TAGE) on Human Health. Cells 2022; 11(14): 2178 doi: 10.3390/cells11142178
|
| 12 |
Junichi Takino, Kentaro Nagamine, Takamitsu Hori. Ras guanyl nucleotide releasing protein 2 affects cell viability and cell–matrix adhesion in ECV304 endothelial cells. Cell Adhesion & Migration 2013; 7(3): 262 doi: 10.4161/cam.24082
|
| 13 |
Yuan Yang, Ling‐Hao Zhao, Bo Huang, Ruo‐Yu Wang, Sheng‐Xian Yuan, Qi‐Fei Tao, Yong Xu, Han‐Yong Sun, Chuan Lin, Wei‐Ping Zhou. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling. Molecular Carcinogenesis 2015; 54(12): 1584 doi: 10.1002/mc.22231
|
| 14 |
Shih-Chi Su, Ming-Ju Hsieh, Ying-Erh Chou, Wen-Lang Fan, Chao-Bin Yeh, Shun-Fa Yang. Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma. Medicine 2015; 94(34): e1396 doi: 10.1097/MD.0000000000001396
|
| 15 |
Sha Li, Wen Liu, Tong‐Tong Wang, Tong‐Qiang Chen, Jin‐Cai Guo. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments. Chemical Biology & Drug Design 2024; 103(1) doi: 10.1111/cbdd.14428
|
| 16 |
Zan Shen, Chen Yao, Zifeng Wang, Lu Yue, Zheping Fang, Hong Yao, Feng Lin, Hui Zhao, Yuan-Jue Sun, Xiu-wu Bian, Wenqi Jiang, Xiaomei Wang, Yi Li, Gang Lu, Wai Sang Poon, Hsiang-Fu Kung, Marie Chia-mi Lin. Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis. Molecular Therapy 2016; 24(8): 1358 doi: 10.1038/mt.2016.56
|
| 17 |
Akiko Sakasai-Sakai, Kenji Takeda, Masayoshi Takeuchi. Involvement of Intracellular TAGE and the TAGE–RAGE–ROS Axis in the Onset and Progression of NAFLD/NASH. Antioxidants 2023; 12(3): 748 doi: 10.3390/antiox12030748
|
| 18 |
Ting-Yu Chang, Kuo-Cheng Lan, Chia-Hung Wu, Meei-Ling Sheu, Rong-Sen Yang, Shing-Hwa Liu. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness. Archives of Toxicology 2023; 97(8): 2231 doi: 10.1007/s00204-023-03539-8
|
| 19 |
Luciana Moreira, João Melo Beirão, Idalina Beirão, Paulo Pinho e Costa. Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B. Amyloid 2015; 22(2): 93 doi: 10.3109/13506129.2015.1007497
|
| 20 |
Ali H. El-Far, Grazyna Sroga, Soad K. Al Jaouni, Shaker A. Mousa. Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression. International Journal of Molecular Sciences 2020; 21(10): 3613 doi: 10.3390/ijms21103613
|
| 21 |
Ejazul Haque, Mohd Kamil, Adria Hasan, Safia Irfan, Saba Sheikh, Aisha Khatoon, Aamir Nazir, Snober S Mir. Advanced glycation end products (AGEs), protein aggregation and their cross talk: new insight in tumorigenesis. Glycobiology 2020; 30(1): 2 doi: 10.1093/glycob/cwz073
|
| 22 |
O. Nedić, S. I. S. Rattan, T. Grune, I. P. Trougakos. Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radical Research 2013; 47(sup1): 28 doi: 10.3109/10715762.2013.806798
|
| 23 |
Ioannis P. Trougakos, Fabiola Sesti, Eleni Tsakiri, Vassilis G. Gorgoulis. Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis. Journal of Proteomics 2013; 92: 274 doi: 10.1016/j.jprot.2013.02.024
|
| 24 |
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. International Journal of Molecular Sciences 2019; 20(20): 5037 doi: 10.3390/ijms20205037
|
| 25 |
Jer‐An Lin, Chi‐Hao Wu, Chi‐Cheng Lu, Shih‐Min Hsia, Gow‐Chin Yen. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression. Molecular Nutrition & Food Research 2016; 60(8): 1850 doi: 10.1002/mnfr.201500759
|
| 26 |
Wiramon Rungratanawanich, Ying Qu, Xin Wang, Musthafa Mohamed Essa, Byoung-Joon Song. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury. Experimental & Molecular Medicine 2021; 53(2): 168 doi: 10.1038/s12276-021-00561-7
|
| 27 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Tadashi Ueda, Mikihiro Tsutsumi, Hideyuki Hyogo, Sho-ichi Yamagishi. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World Journal of Hepatology 2014; 6(12): 880-893 doi: 10.4254/wjh.v6.i12.880
|
| 28 |
Mohammad Imran Khan, Suvasmita Rath, Vaqar Mustafa Adhami, Hasan Mukhtar. Hypoxia driven glycation: Mechanisms and therapeutic opportunities. Seminars in Cancer Biology 2018; 49: 75 doi: 10.1016/j.semcancer.2017.05.008
|
| 29 |
Hai-Bo Lang, Ru-Xin Xie, Min-Li Huang, Li-Ying Fang, Yin-Bin Tang, Fan Zhang. The Effect and Mechanism of TRPC1, 3, and 6 on the Proliferation, Migration, and Lumen Formation of Retinal Vascular Endothelial Cells Induced by High Glucose. Ophthalmic Research 2020; 63(3): 284 doi: 10.1159/000503724
|
| 30 |
Mari Abe-Yutori, Miho Motoyama, Tsuguno Yamaguchi, Mitsuo Kimura, Eiji Nishinaga. Allantoin, dipotassium glycyrrhizinate, and azulene sulfonate sodium hydrate inhibit gingival inflammation induced by advanced glycation end products via antiglycation effects <i>in vitro</i>. Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) 2022; 64(1): 25 doi: 10.2329/perio.64.25
|
| 31 |
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. Biomolecules 2021; 11(3): 387 doi: 10.3390/biom11030387
|
| 32 |
Jun-ichi Takino, Kentaro Nagamine, Takamitsu Hori, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World Journal of Hepatology 2015; 7(23): 2459-2469 doi: 10.4254/wjh.v7.i23.2459
|
| 33 |
Masayoshi Takeuchi. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases. Diagnostics 2016; 6(2): 23 doi: 10.3390/diagnostics6020023
|
| 34 |
Hui Han, Romain Desert, Sukanta Das, Zhuolun Song, Dipti Athavale, Xiaodong Ge, Natalia Nieto. Danger signals in liver injury and restoration of homeostasis. Journal of Hepatology 2020; 73(4): 933 doi: 10.1016/j.jhep.2020.04.033
|
| 35 |
Jing Liu, Zhedong Jin, Xiaolong Wang, Tanja Jakoš, Jianwei Zhu, Yunsheng Yuan. RAGE pathways play an important role in regulation of organ fibrosis. Life Sciences 2023; 323: 121713 doi: 10.1016/j.lfs.2023.121713
|
| 36 |
Nasimudeen R. Jabir, Saheem Ahmad, Shams Tabrez. An insight on the association of glycation with hepatocellular carcinoma. Seminars in Cancer Biology 2018; 49: 56 doi: 10.1016/j.semcancer.2017.06.005
|
| 37 |
Donald S. Backos, Kristofer S. Fritz, Debbie G. McArthur, Jadwiga K. Kepa, Andrew M. Donson, Dennis R. Petersen, Nicholas K. Foreman, Christopher C. Franklin, Philip Reigan. Glycation of Glutamate Cysteine Ligase by 2-Deoxy-d-Ribose and its Potential Impact on Chemoresistance in Glioblastoma. Neurochemical Research 2013; 38(9): 1838 doi: 10.1007/s11064-013-1090-4
|
| 38 |
Ariel Jaffe, Mario Strazzabosco. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_51-1
|
| 39 |
Rui Wu, Liang Duan, Fang Cui, Ju Cao, Yu Xiang, Yishu Tang, Lan Zhou. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. Experimental Cell Research 2015; 334(2): 228 doi: 10.1016/j.yexcr.2015.04.008
|
| 40 |
Xuanbin Wang, Longchao Xiang, Hongliang Li, Ping Chen, Yibin Feng, Jingxuan Zhang, Nian Yang, Fei Li, Ye Wang, Quifang Zhang, Fang Li, Fengjun Cao. The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review. International Journal of Molecular Sciences 2015; 16(9): 22527 doi: 10.3390/ijms160922527
|
| 41 |
Agnieszka Bronowicka-Szydełko, Łukasz Kotyra, Łukasz Lewandowski, Andrzej Gamian, Irena Kustrzeba-Wójcicka. Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression. Journal of Clinical Medicine 2021; 10(18): 4084 doi: 10.3390/jcm10184084
|
| 42 |
Sho-ichi Yamagishi, Takanori Matsui, Kei Fukami. Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk. Rejuvenation Research 2015; 18(1): 48 doi: 10.1089/rej.2014.1625
|
| 43 |
Hiromi Kan, Sho‐ichi Yamagishi, Ayako Ojima, Kei Fukami, Seiji Ueda, Masayoshi Takeuchi, Hideyuki Hyogo, Hiroshi Aikata, Kazuaki Chayama. Elevation of Serum Levels of Advanced Glycation End Products in Patients With Non‐B or Non‐C Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis 2015; 29(6): 480 doi: 10.1002/jcla.21797
|
| 44 |
Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Masayoshi Takeuchi. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14711-3
|
| 45 |
Xuebo Chen, Leying Zhang, Ian Y. Zhang, Junling Liang, Huaqing Wang, Mao Ouyang, Shihua Wu, Anna Carolina Carvalho da Fonseca, Lihong Weng, Yasuhiko Yamamoto, Hiroshi Yamamoto, Rama Natarajan, Behnam Badie. RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma. Cancer Research 2014; 74(24): 7285 doi: 10.1158/0008-5472.CAN-14-1240
|
| 46 |
Narasimha M. Beeraka, Venugopal R. Bovilla, Shalini H. Doreswamy, Sujatha Puttalingaiah, Asha Srinivasan, SubbaRao V. Madhunapantula. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers. Cancers 2021; 13(2): 281 doi: 10.3390/cancers13020281
|
| 47 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3409 doi: 10.1007/978-3-319-26956-6_185
|
| 48 |
Chisato Saeki, Mitsuru Saito, Akihito Tsubota. Plasma pentosidine as a useful biomarker of sarcopenia, low gait speed, and mortality in patients with cirrhosis. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1212899
|
| 49 |
Ariel Jaffe, Mario Strazzabosco. Hepato-Pancreato-Biliary Malignancies. 2022; : 87 doi: 10.1007/978-3-030-41683-6_51
|
| 50 |
Ahmed Abdel-Razik, Walaa Shabana, Ahmed Mohamed El Nakib, Mostafa Abdelsalam, Ahmed Abdelwahab, Ahmad S. Hasan, Rasha Elzehery, Rania Elhelaly, Aya Ahmed Fathy, Sally Abdallah Mostafa, Niveen El-Wakeel, Dalia Moemen, Waleed Eldars, Ahmed H. Yassen. De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.662431
|
| 51 |
M. Takeuchi, A. Sakasai-Sakai, T. Takata, T. Ueda, J. Takino, M. Tsutsumi, H. Hyogo, S. Yamagishi. Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. Medical Hypotheses 2015; 84(5): 490 doi: 10.1016/j.mehy.2015.02.002
|
| 52 |
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017; 9(6): 634 doi: 10.3390/nu9060634
|